Compare QBTS & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QBTS | KRMD |
|---|---|---|
| Founded | 1999 | 1980 |
| Country | United States | United States |
| Employees | 388 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 192.5M |
| IPO Year | N/A | 2019 |
| Metric | QBTS | KRMD |
|---|---|---|
| Price | $16.91 | $4.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 4 |
| Target Price | ★ $32.53 | $6.50 |
| AVG Volume (30 Days) | ★ 20.3M | 154.1K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 53.85 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $41,127,366.00 |
| Revenue This Year | $81.05 | $20.32 |
| Revenue Next Year | $93.13 | $17.37 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 22.23 |
| 52 Week Low | $12.75 | $3.20 |
| 52 Week High | $46.75 | $6.61 |
| Indicator | QBTS | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 31.43 | 50.10 |
| Support Level | $12.75 | $4.20 |
| Resistance Level | $22.10 | $4.30 |
| Average True Range (ATR) | 1.48 | 0.23 |
| MACD | -0.58 | -0.03 |
| Stochastic Oscillator | 1.14 | 28.89 |
D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.